Clinical Trial Update: REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma

View source ↗

Summary

REACT, a trial to identify patients with severe uncontrolled asthma, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Bronchial | Status: TERMINATED